gaba

GABA (gamma-aminobutyric acid) is a four-carbon amino acid that acts as the main inhibitory neurotransmitter in the human central nervous system, where it reduces nerve-cell signaling and electrical activity in the brain. The NIH Office of Dietary Supplements dictionary defines it as a chemical found naturally in plants and animals, and in the US it is also sold as an ingredient in dietary supplements. A US Pharmacopeia safety review hosted by the NIH National Library of Medicine notes that only very low amounts of GABA appear to cross from the bloodstream into the brain, so exactly how an orally taken GABA supplement would act on the brain is not well understood.

There is no dedicated NIH Office of Dietary Supplements or NCCIH consumer fact sheet establishing that GABA supplements are effective for any of these uses, and rigorous human evidence is limited. A US Pharmacopeia (USP) safety review hosted on the NIH National Library of Medicine notes that the available studies have generally been small and short, and that very little ingested GABA appears to reach the brain because it does not readily cross the blood-brain barrier, so the practical benefit of oral GABA remains uncertain. The uses listed above should be read as reasons people take the product, not as proven treatment effects.

There is no official recommended dose for GABA. According to the USP safety review, manufacturer labels span a very wide range, with most products suggesting roughly 100 mg per day in divided doses, while clinical studies have used anywhere from a few milligrams up to several grams daily over periods of about 4 to 12 weeks. One product monograph cited in the review (the NNHPD Cognitive Function Products monograph) suggests a daily intake of 50 to 3000 mg without exceeding 750 mg in a single dose. Because the evidence is limited and individual needs differ, talk to a clinician or pharmacist before starting GABA, especially if you take other medicines or have a health condition.

In the studies summarized by the USP review, no serious adverse events were documented at intakes up to 18 g/day for 4 days or 120 mg/day for 12 weeks, and animal toxicology studies reported no signs of toxicity at high doses. However, because GABA can influence neurotransmitters and hormones such as growth hormone and prolactin, the review advises caution during pregnancy and breastfeeding, for which no safety studies were available. As with any supplement, dietary supplements are not reviewed by the FDA for safety and effectiveness before they are sold.

Side effects reported in studies were generally mild, short-lived, and resolved quickly. They included a brief burning feeling in the throat (sometimes accompanied by breathlessness that passed shortly after), abdominal discomfort, headache, drowsiness, dizziness, and lethargy or a sense of weakness in the legs. Some studies also noted a small, temporary drop in blood pressure (less than about 10 percent) that returned to baseline within a few days after people stopped taking GABA.

No authoritative NIH consumer fact sheet details specific drug interactions for GABA. The USP review notes that, given GABA's blood-pressure-lowering effect, taking it alongside antihypertensive (blood-pressure) medicines could increase the risk of low blood pressure. Because GABA also has reported sedative-type, central-nervous-system effects, it is reasonable to be cautious about combining it with sedatives or sleep aids as well. Check with a clinician or pharmacist before combining GABA with any prescription drug.